The Society of Memorial Sloan-Kettering Cancer Center Company Profile

22:35 EDT 2nd July 2015 | BioPortfolio


News Articles [3955 Associated News Articles listed on BioPortfolio]

Immunotherapy combo increases progression-free survival in advanced melanoma patients

(Memorial Sloan Kettering Cancer Center) Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab and ipilimumab or nivolumab alone significantly increases pr...

Atara Biotherapeutics Exercises Exclusive License to T-Cell Technology From Memorial Sloan Kettering Cancer Center

SOUTH SAN FRANCISCO, Calif., June 15, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) today announced that it has exercised its exclusive option with Memorial Sloan Kettering Cance...

SITC Announces Cancer Immunotherapy Clinical Fellowship Award Recipient

MILWAUKEE, WI (PRWEB) June 15, 2015 The Society for Immunotherapy of Cancer (SITC) announced Jonathan Peled, MD, PhD, of Memorial Sloan Kettering Cancer Center, as the recipient of the SITC-Merck C...

Foundation Medicine on the Added Value of NGS Cancer Tests

Clinical Informatics News Brief | Foundation Medicine of Cambridge, Mass., continues to make the case for expansive next-generation sequencing tests as the front line of cancer diagnostics, with a new...

Nanoparticles Capable of Delivering Drugs Directly to Kidney Tumors

Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) have created a tiny device that can deliver cancer therapies directly to the tumor site. What's more, this technology could potentially tr...

Cancer: Colon-cancer cells made normal

By turning on a particular gene, researchers have made colon-cancer cells in mice revert back to normal ones.Scott Lowe at the Memorial Sloan Kettering Cancer Center in New York and his colleagues eng...

Nanoparticles Capable of Deliver Drugs Directly to Kidney Tumors

Researchers at Memorial Sloan Kettering Cancer Center (MSKCC) have created a tiny device that can deliver cancer therapies directly to the tumor site. What's more, this technology could potentially tr...

FoundationOne® Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer

65% of Patients Found to Have GAs Tied to Available Therapeutic Options Data Published in Clinical Cancer Research Foundation Medicine, Inc. (NASDAQ:FMI...

PubMed Articles [8940 Associated PubMed Articles listed on BioPortfolio]

Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center.

Few studies have examined melanoma and non-melanoma skin cancer (NMSC) incidence rates after a diagnosis of hairy cell leukaemia (HCL). We assessed 267 HCL patients treated at Memorial Sloan Kettering...

Back to the Future: Are Tumor-Targeting Bacteria the Next-Generation Cancer Therapy?

Cancer patients infected with various bacteria were reported, for at least two centuries, to have spontaneous remission. W.B. Coley, of what is now the Memorial Sloan-Kettering Cancer Center, pioneere...

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.

We compared outcomes of adult patients receiving T-cell-depleted (TCD) hematopoietic SCT (HCT) without additional GVHD prophylaxis at Memorial Sloan Kettering Cancer Center (MSKCC, N=52), with those o...

A Conversation with Susan Band Horwitz.

Introduction Susan Band Horwitz is a Distinguished Professor and holds the Falkenstein Chair in Cancer Research at Albert Einstein College of Medicine in New York. She is co-chair of the Department of...

New roles & responsibilities of hospital biomedical engineering.

Over the last decade the changing healthcare environment has required hospitals and specifically Biomedical Engineering to critically evaluate, optimize and adapt their operations. The focus is now on...

Clinical Trials [3629 Associated Clinical Trials listed on BioPortfolio]

Measurement of Cancer-Related Risk Perception in Smokers

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Cen...

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy

With a major liver or pancreas operation, there is a chance that one will require a transfusion of blood products (either red blood cells or plasma). This may be necessary during the oper...

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes...

A Randomized Study of Sulindac in Oral Premalignant Lesions

The purpose of this study is to see if a drug called sulindac can prevent the development of changes in the mouth that are related to oral pre-cancer growths (oral epithelial dysplasia) or...

Behavioral Intervention For BMT/SCT Survivors

The purpose of this study is to understand how to help survivors of bone marrow transplant and stem cell transplant (BMT/SCT) with emotional distress. BMT/SCT has become a more common type...

Companies [3183 Associated Companies listed on BioPortfolio]

Memorial Sloan-Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center's tradition of care began more than 100 years ago. In 1884, the cornerstone of the New York Cancer Hospital -- what was later to become Memorial Hospital for Can...

The Society of Memorial Sloan-Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

The CMO’s Structure, Assets, and Goals

Optimer Pharmaceuticals

Optimer's core competence includes the development of innovative drugs for treating diseases that currently have no satisfactory therapy. These include antibiotics for drug-resistant bacterial infecti...

Mojave Therapeutics Incorporated

Mojave Therapeutics is building a new class of biopharmaceuticals that primes the immune system to fight cancer and viral diseases. Mojave’s core technologies, developed by leading researchers at Me...

More Information about "The Society of Memorial Sloan-Kettering Cancer Center" on BioPortfolio

We have published hundreds of The Society of Memorial Sloan-Kettering Cancer Center news stories on BioPortfolio along with dozens of The Society of Memorial Sloan-Kettering Cancer Center Clinical Trials and PubMed Articles about The Society of Memorial Sloan-Kettering Cancer Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Society of Memorial Sloan-Kettering Cancer Center Companies in our database. You can also find out about relevant The Society of Memorial Sloan-Kettering Cancer Center Drugs and Medications on this site too.


Advertisement
 
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record